Drug Development

Clinical Trials Pharmaceutical Research Weight-loss Drugs Regulatory Approval FDA Approval Clinical Research FDA Regulations Therapeutic Research Research Studies Oncology RNA-based Therapeutics Mifepristone Ruling Phase 3 Trials Stelara Loss of Exclusivity Disease Treatment GLP-1 Drugs Experimental Treatments Intellectual Property Injectable Medications Biotechnology Gene Therapy Research Applications Innovative Therapies Therapeutic Segments Combination Therapy Alzheimer's Disease Therapeutics Alzheimer's Scientific Research Biologics Preclinical Research

Alkermes to Buy Avadel in Up to $2.1 Billion Deal With CVR Tied to Lumryz Expansion

A same-day patent settlement with Jazz clears the path for Lumryz as Alkermes targets a faster push into sleep medicine.

BioCryst to Acquire Astria in $700 Million Cash-and-Stock Deal to Bolster HAE Portfolio